Correlation Between Enveric Biosciences and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Immix Biopharma, you can compare the effects of market volatilities on Enveric Biosciences and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Immix Biopharma.
Diversification Opportunities for Enveric Biosciences and Immix Biopharma
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enveric and Immix is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Immix Biopharma go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Immix Biopharma
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Immix Biopharma. In addition to that, Enveric Biosciences is 1.37 times more volatile than Immix Biopharma. It trades about -0.01 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.05 per unit of volatility. If you would invest 108.00 in Immix Biopharma on August 27, 2024 and sell it today you would earn a total of 71.00 from holding Immix Biopharma or generate 65.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enveric Biosciences vs. Immix Biopharma
Performance |
| Timeline |
| Enveric Biosciences |
| Immix Biopharma |
Enveric Biosciences and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Immix Biopharma
The main advantage of trading using opposite Enveric Biosciences and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |